Pfizer Inc. (PFE)
26.53
+0.08
(+0.30%)
USD |
NYSE |
May 06, 16:00
26.48
-0.05
(-0.19%)
Pre-Market: 07:07
Pfizer Cash from Investing (Quarterly) : 785.00M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -716.00M |
| Gilead Sciences, Inc. | -1.835B |
| Johnson & Johnson | -1.04B |
| Regeneron Pharmaceuticals, Inc. | -428.90M |
| Moderna, Inc. | -76.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.615B |
| Cash from Financing (Quarterly) | -2.856B |
| Free Cash Flow | 9.484B |
| Free Cash Flow Per Share (Quarterly) | 0.3802 |
| Free Cash Flow to Equity (Quarterly) | 5.14B |
| Free Cash Flow to Firm (Quarterly) | 2.750B |
| Free Cash Flow Yield | 6.26% |